Šalis: Vietnamas
kalba: vietnamiečių
Šaltinis: BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)
Levetiracetam
GlaxoSmithKline Pte., Ltd.
Levetiracetam
500mg
Viên nén bao phim
Hộp 6 vỉ x 10 viên
Thuốc kê đơn
UCB Pharma SA
Tiêu Chuẩn: NSX; Tuổi Thọ: 36 tháng; Tá dược: Natri croscarmelose, Macrogol 6000, Coloidal silica khan, Magnesi stearat, Opadry 85F32004, Cồn polyvinyl thủy phân một phần, Titan dioxyd (E171), Macrogol 3350, Talc, Oxit sắt vàng (E172)
YE9W/1(Y2 xÓ wher 500mg doit UCS FHARMA S.A, GELGIUM UCB PHARMAS.A,RELGIUM —UCA PHARMA S.A, BELOIUM ae 500mg UM «UCR PHARMAS.A, BELGIUM © UCAPHARMAS,A, BELGIUM «UCB PHARNASA, BELGIUM UDBPHARMA Ÿ4 LZZ Kenora’ [eppra’ 500mg i 500mg 500mg i 500mg UCB PHARMA $3.4, BELGIUM UCB FHARMA § A, BELGIUM UC FHARMA @A, BELGIUM UCB PHARMA 9A, BELGIUM ore” Kenora | ® Kenora’ Keen Kens i en Fer 1 900mg i 500mg h 500mg i ‘ A BELGIUM (UCB PHARMA $.4, BELGIUM UGA PHARMA S.A, BELGIUM UCB PHARMA S.A, BELGIUM ucn PHAnMA a ` , : ` \ 500mg 500mg ì 500mg i 300mg UCBPHARMAS.A,ELGUM UCBPHARMAS.A,BELGIUM LUCBPHARMASA,BELGIUM UCBPHARMAS.A,BELGIUM pra’ Keppra’ Keppra’ epnra' 1 500mg 500mg 4 A,HELBIIM UCR PHARMA ZA, pcan UCH FHAAMA S.A, BELGIUM © UCB PHARMAS.A, Kha UCR PHARMA [6 500mg ‡ i 500mg UCH PHARMA S.A,RELGIUM UGB PHARMA E.A,RELGIUM UCHPHARMARA,RELOIIM UCR PHARMA ILA, BELGIUM 1 500mg h 500mg i 500mg 300mg A, BELGIUM UGB PHARMA §.A,BELGIUM UCE PHARMA B A, BELGIUM GB PHARMA 5A, BELGIUM LIGB PHARMA B2, Kevera’ Kenera' Kenxra' Kem: 500mg ì 500mg i ì 500mg UCB PHARMA SA,RELGIUM © UCE PHARMAS.A, BELGIUM © UCB PHARWAS.A,RELGIUM UGS PHARMA 8.A, BELGIUM ^” BO Y TE A lá OC ĐÃ PHE DUYET “ Lhuôhulbu 2 CỤC QUẢN LÝ D ^ lâu an d ^ L ‘Alu. foil printed on inside af rol ) LII L12 L3 04 * AjVjmj4j Au. fall printed on outside of roll ; Ajvj>j«j 0506 07 &a BRAINE-ADDITIONAL ARTWORK INFORMATION PANEL Kepora’ levethacetam 500 mg ‘UCR PHARMA § A, BELGIUM vs£rrvD PRODUCT NAME: Keppra COLOUR: 180 ROLL WIDTH: 110 mm REPETITIONS: 34 mm IMPORTANT GSK Market is responsible for this product, its design and content. Ensure the artwork is thoroughly checked, all the text proof-read and approved. RSC GSK is responsible for site technical requirements and pre-press suitability. GSK Market is responsible to advise RSC in case changes required impact the followings: Formulation, Tablet embossing, Storage conditions, Shelf Life This PDF has been verified using PitStop 08 - PDF is PDF/X-1a compliant (Flexibles workfl Perskaitykite visą dokumentą